{"title": "Sorry, your browser does not support JavaScript!", "author": null, "url": null, "hostname": null, "description": "See Emergency Use Authorization for Pfizer-BioNTech COVID-19 Vaccine to help prevent COVID-19 caused by SARS-CoV-2.", "sitename": null, "date": "2023-03-14", "cleaned_text": "Indication & Authorized Use The FDA-approved COMIRNATY\u00ae (COVID-19 Vaccine, mRNA) and the EUA-authorized Pfizer-BioNTech COVID-19 Vaccine have the same formulation and can be used interchangeably to provide the COVID-19 vaccination series. Indication COMIRNATY\u00ae is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 16 years of age and older. Authorized Use COMIRNATY\u00ae (COVID-19 Vaccine, mRNA) is also authorized for emergency use in individuals 5 years of age and older and to provide a third dose to individuals 12 years of age and older who have been determined to have certain kinds of immunocompromise. The Pfizer-BioNTech COVID-19 Vaccine has received Emergency Use Authorization (EUA) from FDA to prevent COVID-19 in individuals 5 years of age and older, and provide a third dose to individuals 12 years of age and older who have been determined to have certain kinds of immunocompromise. The FDA-approved COMIRNATY\u00ae (COVID-19 Vaccine, mRNA) and the EUA-authorized Pfizer-BioNTech COVID-19 Vaccine have the same formulation and can be used interchangeably to provide the COVID-19 vaccination series. COMIRNATY\u00ae has the same formulation as the authorized vaccine Pfizer-BioNTech COVID-19 Vaccine, and they can be used interchangeably without presenting any safety or effectiveness concerns. Although they may be manufactured in different facilities, the products offer the same safety and effectiveness. "}